Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,027 | 4,192 | 2,772 | 102 | 19,411 |
| Depreciation Amortization | 1,242 | 557 | 368 | 167 | 603 |
| Accounts receivable | -12,367 | -11,647 | -6,054 | 2,236 | N/A |
| Accounts payable and accrued liabilities | -256 | 486 | -149 | 112 | N/A |
| Other Working Capital | -8,646 | -10,653 | -7,241 | 557 | -7,536 |
| Other Operating Activity | 21,630 | 16,247 | 8,325 | -1,239 | 2,678 |
| Operating Cash Flow | $4,630 | $-818 | $-1,979 | $1,935 | $15,156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,364 | -3,068 | -1,760 | -509 | -1,547 |
| Net Acquisitions | -17,000 | N/A | N/A | N/A | 0 |
| Purchase Of Investment | 371 | 371 | 371 | 371 | N/A |
| Investing Cash Flow | $-20,993 | $-2,697 | $-1,389 | $-138 | $-1,547 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,772 | -2,772 | -2,772 | N/A | N/A |
| Common Stock Issued | 216,331 | 216,314 | 317 | 187 | N/A |
| Other Financing Activity | 0 | 0 | -1,081 | 0 | 122,607 |
| Financing Cash Flow | $213,559 | $213,542 | $-3,536 | $187 | $122,607 |
| Exchange Rate Effect | 1,303 | 625 | 631 | 481 | -587 |
| Beginning Cash Position | 166,119 | 166,119 | 166,119 | 166,119 | 30,490 |
| End Cash Position | 364,618 | 376,771 | 159,846 | 168,584 | 166,119 |
| Net Cash Flow | $198,499 | $210,652 | $-6,273 | $2,465 | $135,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,630 | -818 | -1,979 | 1,935 | 15,156 |
| Capital Expenditure | -4,364 | -3,068 | -1,760 | -509 | N/A |
| Free Cash Flow | 266 | -3,886 | -3,739 | 1,426 | 15,156 |